| Autor: |
Ammirati AL; Doutor em Nefrologia pela Universidade Federal de São Paulo, São Paulo, SP, Brasil.; Coordenador Ambulatório de Uremia, Universidade Federal de São Paulo, São Paulo, SP, Brasil. |
| Jazyk: |
angličtina |
| Zdroj: |
Revista da Associacao Medica Brasileira (1992) [Rev Assoc Med Bras (1992)] 2020 Jan 13; Vol. 66Suppl 1 (Suppl 1), pp. s03-s09. Date of Electronic Publication: 2020 Jan 13. |
| DOI: |
10.1590/1806-9282.66.S1.3 |
| Abstrakt: |
Chronic kidney disease is highly prevalent (10-13% of the population), irreversible, progressive, and associated with higher cardiovascular risk. Patients with this pathology remain asymptomatic most of the time, presenting the complications typical of renal dysfunction only in more advanced stages. Its treatment can be conservative (patients without indication for dialysis, usually those with glomerular filtration rate above 15 ml/minute) or replacement therapy (hemodialysis, peritoneal dialysis, and kidney transplantation). The objectives of the conservative treatment for chronic kidney disease are to slow down the progression of kidney dysfunction, treat complications (anemia, bone diseases, cardiovascular diseases), vaccination for hepatitis B, and preparation for kidney replacement therapy. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
